2022
DOI: 10.1080/08820538.2022.2095873
|View full text |Cite
|
Sign up to set email alerts
|

Donor related corneal graft infection: a review of literature and preventive strategies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…In this perspective, nanotechnology emerges as a potential alternative for efficient ocular drug delivery, leading to the development of one of the first FDA approved nanoformulations, a liposomal formulation of the drug, amBisome. [13,14] Despite the development of various biodegradable nanoformulations of amphotericin B, [15][16][17][18][19][20][21] they are limited in their clinical outcomes owing to emergence of multi-drug resistance in fungal microbial species, [22][23][24][25][26] indicating the need for developing further advanced therapeutic strategies.…”
Section: Introductionmentioning
confidence: 99%
“…In this perspective, nanotechnology emerges as a potential alternative for efficient ocular drug delivery, leading to the development of one of the first FDA approved nanoformulations, a liposomal formulation of the drug, amBisome. [13,14] Despite the development of various biodegradable nanoformulations of amphotericin B, [15][16][17][18][19][20][21] they are limited in their clinical outcomes owing to emergence of multi-drug resistance in fungal microbial species, [22][23][24][25][26] indicating the need for developing further advanced therapeutic strategies.…”
Section: Introductionmentioning
confidence: 99%